SS
ABOS icon

SBI Securities’s Acumen Pharmaceuticals ABOS Stock Holding History

SBI Securities’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$777 Sell
291
-12
-4% -$30 ﹤0.01% 2890
2026
Q1 		$715 Sell
303
-20
-6% -$51 ﹤0.01% 2773
2025
Q4 		$682 Sell
323
-195
-38% -$387 ﹤0.01% 2763
2025
Q3 		$886 Buy
518
+5
+1% +$7 ﹤0.01% 2746
2025
Q2 		$595 Hold
513
– – ﹤0.01% 2899
2025
Q1 		$564 Buy
513
+73
+17% +$104 ﹤0.01% 2820
2024
Q4 		$757 Buy
+440
New +$1.06K ﹤0.01% 2735

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

SBI Securities's ABOS Position: Q2 2026 in Review

SBI Securities reduced its Acumen Pharmaceuticals (ABOS) stake by 4% in Q2 2026, selling an estimated $30 and leaving 291 shares worth $777. The position accounts for ﹤0.01% of the portfolio, ranked #2890.

SBI Securities first reported a position in ABOS in Q4 2024 and has held it in 7 quarters since. The position peaked at $886 in Q3 2025. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • SBI Securities held 291 shares of Acumen Pharmaceuticals worth $777 as of Q2 2026.
  • SBI Securities sold 12 Acumen Pharmaceuticals shares in Q2 2026, an estimated $30.
  • Acumen Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2890 holding.
  • SBI Securities first reported a position in Acumen Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Acumen Pharmaceuticals position peaked at $886 in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.